Diabetic Eye Disease
Diabetic Macular Oedema:
- Anti-VEGF intravitreal injections of Vabysmo (Faricimab)
- Anti-VEGF intravitreal injections of Eylea (Aflibercept)
- Anti-VEGF intravitreal injections of Lucentis (Ranibizumab)
- Anti-VEGF intravitreal injections of Avastin (Bevacizumab)
- Intravitreal Fluocinolone implant (Iluvien 190mcg)
- Focal or grid macular laser treatment
Proliferative diabetic retinopathy
- Pan-retinal laser photocoagulation (PRP)
- Anti-VEGF intravitreal injections of Avastin (Bevacizumab)
Diabetic eye disease treatment aims to prevent vision loss, reduce retinal swelling, and control disease progression. Early diagnosis and intervention are crucial for preserving vision and preventing complications.
Diabetic Macular oedema is treated with anti-VEGF injections, which help reduce fluid leakage and swelling in the retina. Medications such as Vabysmo, Eylea, Lucentis, and Avastin inhibit vascular endothelial growth factor (VEGF), a protein that promotes abnormal blood vessel growth and increases vascular permeability. Intravitreal steroid implants such as Dexamethasone implants (Ozurdex) and Fluocinolone implants (Iluvien) provide a sustained release of corticosteroids directly into the eye, offering long-term control of inflammation. Focal or grid macular laser treatment is also used to target specific areas of the retina to reduce oedema and stabilise vision.
Proliferative Diabetic Retinopathy involves the growth of new, abnormal blood vessels on the surface of the retina, which can lead to severe vision loss. Pan-retinal laser photocoagulation (PRP) is a standard treatment that creates laser burns in the peripheral retina, reducing the growth of abnormal blood vessels and preserving central vision. Anti-VEGF injections of Avastin are also used to inhibit abnormal blood vessel growth and reduce the risk of bleeding and vision loss.
What our patients say
Russell K.
Philippa B.
Duncan C.
Christina Z.
Cruise E.
Jill W.
Book an appointment
Booking an appointment with Ms Ranjit Sandhu is the first step towards managing diabetic eye disease and protecting your vision. We offer convenient and flexible appointment scheduling to accommodate your needs.
Anti-VEGF injections help reduce retinal swelling, inhibit the growth of abnormal blood vessels, and improve vision. These treatments are essential in managing diabetic macular oedema and proliferative diabetic retinopathy.
Recovery time varies depending on the severity of the condition and the treatment used. Anti-VEGF injections often require ongoing treatments, while laser treatments may have a shorter recovery period. Your ophthalmologist will provide detailed care instructions and schedule follow-up appointments to monitor your progress.
Gov.UK: Guide to diabetic retinopathy
Diabetes UK: Retinopathy
Our Price List
Full panretinal laser photocoagulation (PRP) x 3 sessions | £1200 |
Fill-in panretinal laser photocoagulation (PRP) x 1 session | £450 |
Avastin eye injection | £750 |
Lucentis eye injection | £1,700 |
Eylea eye injection | £1,800 |
Vabysmo eye injection | £1,950 |
Ozurdex eye injection | £2,800 |
Iluvien eye injection x 1 (lasts 36 months) | £8,500 |